Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any arthrogryposis-renal dysfunction-cholestasis syndrome in which the cause of the disease is a mutation in the VIPAS39 gene.
Features include always present findings: Aminoaciduria, Enlarged liver (hepatomegaly), Glycosuria, and Metabolic acidosis and others; and sometimes findings: Nephrogenic diabetes insipidus and Lissencephaly. 29 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 5 | Nephrocalcinosis, Renal tubular acidosis, Kidney disease (nephropathy) |
VIPAS39 function has not been fully characterized.
Arthrogryposis, renal dysfunction, and cholestasis 2 is caused by mutations in the VIPAS39 gene on chromosome 14.
Genetic testing for VIPAS39 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 8 always present features.
No clinical trials have been registered for arthrogryposis, renal dysfunction, and cholestasis 2.
5 publications have been identified in PubMed for arthrogryposis, renal dysfunction, and cholestasis 2. Research spans Case Report / Case Series (60%) and Review / Meta-Analysis (40%).
Moustafa M (2026). [PMID: 41923461](https://pubmed.ncbi.nlm.nih.gov/41923461/). *Int J Surg Pathol*. [Case Report / Case Series]
Díaz-Ajenjo L (2026). [PMID: 41138802](https://pubmed.ncbi.nlm.nih.gov/41138802/). *J Thromb Haemost*. [Case Report / Case Series]
Yao HHY (2025). [PMID: 39617187](https://pubmed.ncbi.nlm.nih.gov/39617187/). *J Thromb Haemost*. [Review / Meta-Analysis]
Darouich S (2025). [PMID: 39856600](https://pubmed.ncbi.nlm.nih.gov/39856600/). *Pediatr Dev Pathol*. [Case Report / Case Series]
Kafol J (2024). [PMID: 39736737](https://pubmed.ncbi.nlm.nih.gov/39736737/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 2:56 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Digestive system |
5 |
Enlarged liver (hepatomegaly), Giant cell hepatitis, Elevated circulating hepatic transaminase concentration |
Muscles | 3 | Low muscle tone (hypotonia), Generalized hypotonia, Joint stiffness present at birth (arthrogryposis multiplex congenita) |
Heart and blood vessels | 2 | Ventricular septal defect, Right ventricular hypertrophy |
Lab test results | 2 | Elevated circulating hepatic transaminase concentration, Conjugated hyperbilirubinemia |
Skin | 2 | Dry, scaly skin (ichthyosis), Pruritus |
Growth and development | 1 | Failure to thrive |
Metabolism | 1 | Metabolic acidosis |
Head and neck | 1 | Microcephaly |
Hormones | 1 | Nephrogenic diabetes insipidus |
Brain and nerves | 1 | Global developmental delay |